Daniel Palmacci
Head and President Specialized Modalities, Member of Lonza Executive Committee
Lonza•Basel, Switzerland
View LinkedIn ProfileExecutive Overview
At Lonza, we work to enable a healthier world as a global partner to the pharma, biotech, cell& gene and nutrition markets. We combine world-class manufacturing, scientific expertise and process excellence to support our customers in commercializing new and innovative therapies that help treat a wide range of diseases. We have a vision to bring any therapy to life, and we work to achieve this by focusing on five strategic priorities: service, scope, sustainability, solutions and speed Working in healthcare industry for over 20 years, I had the opportunity to hold multiple leadership positions in different pharmaceutical companies in different countries and managed multi-billion Dollar budgets. At MSD I was leading the commercialization for Merck's biologics & vaccine's novel facilities network and was accountable for several novel facilities. At Novartis I was heading the Sandoz business in Austria and was responsible for the Biologics Drug Substance Sites located in Austria, Germany, France, Slovenia/Switzerland and Singapore. During my assignments for Bayer and Schering, I established new sites in North and South America to launch and broaden new biotech products and biosimilars. In all my positions I was leading large-scale, cross-functional and multi-cultural teams up to thousands of people. As a leader, I believe my most important job is to find and enable talent, set clear targets and offer people an environment to grow, where they can deliver their best work.
Career Timeline
- LonzaCurrentNov 2022–Present· 3 yrs 10 mos
- President, Specialized Modalities, Member of Lonza Executive CommitteeCurrentApr 2025–Present
- President Cell and Gene Division at Lonza, Member of Lonza Executive CommitteeNov 2022–Apr 2025
- LOWENCO A/SCurrentSep 2022–Present· 4 yrs
- Member, Board of DirectorsCurrentSep 2022–Present
- Jul 2020–Nov 2022· 2 yrs 4 mos
- SVP, Global Head of Technical Operations, Member of the Executive CommitteeJul 2020–Nov 2022
- Jul 2019–Jun 2020· 11 mos
- Global Head, Vaccines & Biologics Strategic Facility CreationJul 2019–Jun 2020
- Nov 2013–Jun 2019· 5 yrs 7 mos
- Global Head Bioproduction & CEO Sandoz GmbH, AustriaMay 2018–Jun 2019
- Site Head DP SchaftenauMay 2017–Apr 2018
- Global Head Portfolio Management Biosimilars at SandozSep 2015–Apr 2017
- Global Head External Supplier Operations BiopharmaceuticalsSep 2015–Apr 2017
- Global Head Technical Operations Biopharmaceuticals at SandozMar 2015–Sep 2015
- Global Product Leader & Global Head MS&T Biopharmaceuticals & Oncology Injectables at SandozNov 2013–Mar 2015
- Sep 2008–Sep 2013· 5 yrs
- Head of Manufacturing Biopharmaceuticals DSSep 2008–Sep 2013
- 2001–Aug 2008· 7 yrs 7 mos
- Director, Supply OperationsApr 2006–Aug 2008
- Project Manager Capital Investment2002–Dec 2003
- Project Manager Capital Investment2001–Dec 2001
Education
Corporate University, General
Duke University - The Fuqua School of BusinessMaster
Chemistry and Chemical Engineering
Technische Universität Berlin